Skip to content
stoqly

Verisk Analytics

VRSK Nasdaq Research & Consulting Services Financials FY2016–FY2025

Verisk Analytics' revenue rose 6.6% to $3.1 billion in fiscal 2025. Its operating margin was 43.7%, up from 43.5% a year earlier. Free cash flow was $1.2 billion, up 29.5%. It paid out $875 million in dividends and buybacks, 73% of free cash flow. The diluted share count fell 1.9%.

Last close · Oct 23, 2026

$195.88

3.7%
Value it Compare
Revenue Total sales reported in the income statement.
$3.1B
6.6% vs prior year
Operating margin Operating income as a share of revenue.
43.7%
0.2 pts
Net income Profit after all expenses, interest and tax.
$908M
5.2%
Free cash flow Cash from operations minus capital spending.
$1.2B
29.5%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
35.5%
2.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$26.5B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
29.8x
On $6.57 EPS (TTM)

What Verisk Analytics does

No business description yet.

Legal name
Verisk Analytics, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001437749-26-004452
0001442145

Revenue and margins

Verisk Analytics had $3.1B of revenue in fiscal 2025, up 6.6% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 7.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $1.2B in fiscal 2025, 38.8% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Verisk Analytics returned $875M to shareholders in fiscal 2025, 73% of free cash flow. The diluted share count fell 1.9%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Verisk Analytics yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$2.6B and divides by 140.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 29.8x · peers 26.0x · sector 26.0x.

Balance sheet

Cash, debt and the ratios that show how comfortably Verisk Analytics can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $112M$113M$303M$291M$2.2B
Debt incl. finance leases $3.3B$3.7B$2.9B$3.1B$4.8B
Net debt / EBITDA 2.9x2.3x2.0x1.9x1.6x
Debt / equity 1.2x2.1x9.4x——
Interest coverage 7.2x10.1x9.8x10.1x7.9x
Current ratio 0.5x0.4x1.1x0.7x1.2x
Quick ratio 0.5x0.4x1.1x0.7x1.2x
Total assets $7.8B$7.0B$4.4B$4.3B$6.2B
Total liabilities $5.0B$5.2B$4.0B$4.2B$5.9B
Shareholders' equity $2.8B$1.7B$310M$100M$309M
Net debt (− = net cash) $3.2B$3.6B$2.6B$2.8B$2.6B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$5.3M

4 insiders

Of sales under plans

54%

$2.9M

DateInsiderTradeSharesPriceValueFiling
Oct 15, 2026 Elizabeth MannChief Financial Officer Sold plan 400 $184.85 $0.1M Form 4
Oct 1, 2026 Lee ShavelChief Executive Officer, Director Sold plan 3,535 $170.70 $0.6M Form 4
Sep 15, 2026 Elizabeth MannChief Financial Officer Sold plan 400 $184.91 $0.1M Form 4
Sep 1, 2026 Lee ShavelChief Executive Officer, Director Sold plan 3,535 $193.43 $0.7M Form 4
Aug 17, 2026 Elizabeth MannChief Financial Officer Sold plan 400 $179.95 $0.1M Form 4
Aug 3, 2026 Lee ShavelChief Executive Officer, Director Sold plan 3,535 $196.94 $0.7M Form 4
Jul 31, 2026 Kathy Card BecklesChief Legal Officer Sold 2,020 $195.49 $0.4M Form 4
Jul 29, 2026 Lee ShavelChief Executive Officer, Director Sold plan 2,500 $220.00 $0.6M Form 4
Jul 15, 2026 Elizabeth MannChief Financial Officer Sold plan 400 $192.11 $0.1M Form 4
Jun 15, 2026 Elizabeth MannChief Financial Officer Sold plan 400 $179.54 $0.1M Form 4
Jun 5, 2026 Samuel G LissDirector Sold 4,671 $182.21 $0.9M Form 4
Jun 2, 2026 Samuel G LissDirector Sold 6,765 $177.63 $1.2M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✕ ✕ ✕
Current ratio rose ✓ ✕ ✓
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✓
Revenue rose relative to assets ✓ ✓ ✓
F-score 7 / 97 / 97 / 9
Accruals ratio −7.9%−4.3%−10.1%
Altman Z'' 6.676.976.12

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Verisk Analytics VRSK $26.5B 6.6% 43.7% 38.8% 35.5% 29.8x 7
UL Solutions ULS $15.0B 6.4% 17.1% 13.2% 26.8% 29.6x 7 Compare →
FTI Consulting FCN $4.6B 2.4% 10.3% 2.5% 16.6% 18.9x 4 Compare →
TransUnion TRU $15.8B 9.4% 18.7% 14.5% 7.1% 22.6x 8 Compare →
Equifax EFX $21.5B 6.9% 18.0% 18.7% 8.5% 29.5x 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.0B $2.1B $2.4B $2.6B $2.3B $2.5B $2.5B $2.7B $2.9B $3.1B
Gross profit $1.3B $1.4B $1.5B $1.6B $1.5B $1.6B $1.7B $1.8B $2.0B $2.1B
Research and development $27.4M $37.4M $45.1M $60.0M $44.6M $47.1M $43.1M $36.8M $35.3M $40.9M
Operating income $768M $801M $834M $697M $956M $911M $1.4B $1.1B $1.3B $1.3B
Interest expense $120M $119M $130M $127M $138M $127M $139M $116M $125M $171M
Pretax income $654M $691M $720M $568M $818M $787M $1.3B $1.0B $1.2B $1.2B
Income tax $202M $136M $121M $119M $165M $179M $220M $259M $278M $263M
Net income $591M $555M $599M $450M $713M $666M $954M $615M $958M $908M
Diluted EPS $3.45 $3.29 $3.56 $2.70 $4.31 $4.08 $6.00 $4.17 $6.71 $6.48
Diluted shares 0.17B 0.17B 0.17B 0.17B 0.17B 0.16B 0.16B 0.15B 0.14B 0.14B
Cash flow
Cash from operations $578M $744M $934M $956M $1.1B $1.2B $1.1B $1.1B $1.1B $1.4B
Capital expenditure $157M $184M $231M $217M $247M $268M $275M $230M $224M $244M
Free cash flow $421M $560M $703M $740M $821M $887M $784M $831M $920M $1.2B
Depreciation and amortization $126M $136M $165M $186M $192M $207M $197M $207M $234M $259M
Stock-based compensation $30.0M $31.8M $38.5M $42.7M $47.6M $55.7M $56.5M $54.0M $47.9M $54.2M
Acquisitions $67.7M $873M $138M $699M $276M $290M $449M $83.3M $0.0M $0.0M
Share buybacks $327M $276M $439M $300M $349M $475M $1.7B $2.8B $1.0B $624M
Dividends paid $0.0M $0.0M $0.0M $164M $176M $188M $195M $197M $221M $251M
Dividends and buybacks $327M $276M $439M $464M $525M $663M $1.9B $3.0B $1.2B $875M
Balance sheet
Cash and short-term investments $135M $142M $140M $185M $219M $112M $113M $303M $291M $2.2B
Total debt $2.4B $3.0B $2.7B $3.2B $3.2B $3.3B $3.7B $2.9B $3.1B $4.8B
Finance lease liabilities $0.0M $0.0M $0.0M $7.7M $24.7M $13.3M $4.2M $34.5M $41.4M $23.6M
Current assets $501M $598M $645M $745M $794M $907M $925M $810M $912M $2.8B
Current liabilities $622M $1.3B $1.3B $1.5B $1.4B $1.8B $2.3B $771M $1.2B $2.3B
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Property and equipment, net $380M $478M $556M $548M $632M $531M $542M $605M $606M $583M
Total assets $4.6B $6.0B $5.9B $7.1B $7.6B $7.8B $7.0B $4.4B $4.3B $6.2B
Total liabilities $3.3B $4.1B $3.8B $4.8B $4.9B $5.0B $5.2B $4.0B $4.2B $5.9B
Shareholders' equity $1.3B $1.9B $2.1B $2.3B $2.7B $2.8B $1.7B $310M $100M $309M
Margins
Gross margin 64.2% 63.5% 63.0% 62.5% 65.1% 65.3% 67.0% 67.3% 68.7% 69.9%
Operating margin 38.5% 37.4% 34.8% 26.7% 42.1% 37.0% 56.3% 42.2% 43.5% 43.7%
EBITDA margin 44.8% 43.7% 41.7% 33.9% 50.6% 45.4% 64.2% 49.9% 51.6% 52.2%
Net margin 29.6% 25.9% 25.0% 17.3% 31.4% 27.1% 38.2% 22.9% 33.3% 29.6%
FCF margin 21.1% 26.1% 29.4% 28.4% 36.2% 36.0% 31.4% 31.0% 31.9% 38.8%
Returns
Return on capital 13.2% 15.3% 14.6% 11.1% 13.9% 11.9% 20.2% 20.3% 33.0% 35.5%
Return on capital employed 18.9% 18.4% 18.0% 13.8% 16.4% 15.1% 26.5% 27.5% 37.9% 38.8%
Return on equity 43.7% 34.1% 30.0% 20.8% 28.7% 24.2% 41.8% 59.7% — —
Return on assets 11.6% 10.4% 10.0% 7.0% 9.8% 8.7% 12.9% 10.9% 22.2% 17.4%
Growth
Revenue growth — 7.5% 11.7% 8.9% −13.0% 8.5% 1.4% 7.4% 7.5% 6.6%
Net income growth 16.5% −6.1% 7.9% −24.9% 58.4% −6.5% 43.2% −35.6% 55.9% −5.2%
EPS growth 14.6% −4.6% 8.2% −24.2% 59.6% −5.3% 47.1% −30.5% 60.9% −3.4%
FCF growth −15.4% 33.0% 25.6% 5.1% 11.1% 8.0% −11.6% 5.9% 10.8% 29.5%
Share count change 1.6% −1.5% −0.2% −1.0% −0.7% −1.2% −2.7% −7.3% −3.1% −1.9%
Financial health
Net debt / EBITDA 2.6x 3.1x 2.6x 3.4x 2.6x 2.9x 2.3x 2.0x 1.9x 1.6x
Debt / equity 1.8x 1.6x 1.3x 1.4x 1.2x 1.2x 2.1x 9.4x — —
Interest coverage 6.4x 6.7x 6.4x 5.5x 6.9x 7.2x 10.1x 9.8x 10.1x 7.9x
Current ratio 0.8x 0.5x 0.5x 0.5x 0.6x 0.5x 0.4x 1.1x 0.7x 1.2x
Quick ratio 0.8x 0.5x 0.5x 0.5x 0.6x 0.5x 0.4x 1.1x 0.7x 1.2x
Capital allocation
Capex / revenue 7.8% 8.6% 9.6% 8.3% 10.9% 10.9% 11.0% 8.6% 7.8% 7.9%
Stock comp / revenue 1.5% 1.5% 1.6% 1.6% 2.1% 2.3% 2.3% 2.0% 1.7% 1.8%
Payouts / FCF 77.6% 49.3% 62.4% 62.7% 63.9% 74.7% 236.9% 356.2% 133.3% 73.4%
Quality scores
Piotroski F-score — 6.0 6.0 6.0 8.0 7.0 6.0 7.0 7.0 7.0
Altman Z'' 3.3 2.4 2.9 2.4 2.9 2.8 3.2 6.7 7.0 6.1
Accruals ratio 0.3% −3.5% −5.6% −7.8% −4.9% −6.4% −1.4% −7.9% −4.3% −10.1%

Source: SEC EDGAR XBRL filings (CIK 0001442145). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open